Reglan and Hyzaar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Reglan (metoclopramide hydrochloride) and Hyzaar (hydrochlorothiazide; losartan potassium). Common drug interactions include anaemia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Reglan and Hyzaar. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.

What is Hyzaar?

Hyzaar has active ingredients of hydrochlorothiazide; losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 16,614 Hyzaar users. Check the latest studies of Hyzaar.



On Jul, 12, 2026

77 people who take Reglan and Hyzaar together, and have interactions are studied.

Reglan and Hyzaar drug interactions.

What are the common drug interactions of Reglan and Hyzaar, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Cardiovascular disorder (heart diseases)
  3. Death
  4. Insomnia (sleeplessness)
  5. Platelet count decreased
  6. Asthenia (weakness)
  7. Chills (felling of cold)
  8. Diabetes mellitus inadequate control
  9. Haemorrhage (bleeding)
  10. Pulmonary embolism (blockage of the main artery of the lung)

male:

  1. Anxiety
  2. Pain
  3. Renal failure (kidney dysfunction)
  4. Acute respiratory failure
  5. Atelectasis (partial or complete collapse of the lung)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Cardiomyopathy (weakening of the heart muscle)
  9. Constipation
  10. Coronary artery stenosis (narrowing of coronary artery)

What are the common drug interactions of Reglan and Hyzaar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal pain upper
  2. Chest pain
  3. Colonic polyp (extra part of colon tissue grow in intestine)
  4. Diarrhoea
  5. Dyspepsia (indigestion)
  6. Eructation (release of gas from the digestive tract)
  7. Faecal incontinence (a lack of control over passing stool)
  8. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  9. Irritable bowel syndrome
  10. Lipoma (a growth of fatty tissue that slowly develops just under your skin)

20-29:

n/a

30-39:

  1. Anxiety
  2. Arthralgia (joint pain)
  3. Asthenia (weakness)
  4. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  5. Hallucination (an experience involving the perception of something not present)
  6. Mobility decreased (ability to move is reduced)
  7. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  8. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  9. Pain
  10. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)

40-49:

  1. Cardiovascular disorder (heart diseases)
  2. Chills (felling of cold)
  3. Haemorrhage (bleeding)
  4. Hypotension (abnormally low blood pressure)
  5. Platelet count decreased
  6. Renal failure (kidney dysfunction)
  7. Swelling
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  9. Anaemia (lack of blood)
  10. Blood lactic acid increased

50-59:

  1. Haematocrit decreased
  2. Haemoglobin decreased
  3. Hyperlipidaemia (presence of excess lipids in the blood)
  4. Pain
  5. Presyncope
  6. Ventricular fibrillation (abnormally irregular heart rhythm)
  7. Asthenia (weakness)
  8. Acute respiratory failure
  9. Atelectasis (partial or complete collapse of the lung)
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

60+:

  1. Weight decreased
  2. Blood creatinine increased
  3. Decreased appetite
  4. Diarrhoea
  5. Dry mouth
  6. Dyspnoea (difficult or laboured respiration)
  7. Gingivitis (inflammation of gums)
  8. Pleural effusion (water on the lungs)
  9. Swelling face
  10. Urinary tract infection

What are the existing conditions these people have? *

  1. Pain: 20 people, 25.97%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 18.18%
  3. Depression: 11 people, 14.29%
  4. High Blood Cholesterol: 11 people, 14.29%
  5. Stress And Anxiety: 10 people, 12.99%
  6. Neuralgia (pain in one or more nerves): 9 people, 11.69%
  7. Fibromyalgia (a long-term condition which causes pain all over the body): 8 people, 10.39%
  8. Cardiac Disorder: 8 people, 10.39%
  9. Impaired Gastric Emptying: 8 people, 10.39%
  10. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 7 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Reglan and Hyzaar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Reglan and Hyzaar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hyzaar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reglan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hyzaar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride and hydrochlorothiazide; losartan potassium (the active ingredients of Reglan and Hyzaar, respectively), and Reglan and Hyzaar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: